Email Updates

You are here

Home

HIV Vaccine

An HIV vaccine is imperative for an enduring end to the epidemic.

An effective preventive HIV vaccine would teach the body how to prevent HIV infection. Vaccines are the most powerful public health tool—and an HIV vaccine would play an essential role in ensuring the end to the AIDS epidemic.

While effective vaccines remain years away, there are more reasons for hope than ever before. HIV vaccine research is more productive than ever, with multiple large-scale vaccine trials underway and dozens of vaccine approaches in development.

What We're Reading

First COVID, Now HIV. Moderna and San Diego Researchers Race To Make a Vaccine

Researchers plan to use a series of shots to teach people’s immune systems to produce powerful antibody responses against the virus. But while the strategy is raising hopes and is built on years of research, there’s no guarantee it succeeds.

October 7, 2021
HIV Vaccine
San Diego Union-Tribune

Will the Moderna HIV Vaccine Trials Succeed?

On August 11, Moderna, the biotech company behind one of the COVID-19 vaccines, posted a study record announcing that they were set to start Phase 1 of human trials on a HIV mRNA vaccine. These trials will consist of 56 adults between the ages of 18 to 50 years old who don't have HIV and test for safety, immune responses and antibodies.

September 1, 2021
HIV Vaccine
Paper
Featured Resources

HIV Vaccine Research: Building on the Lessons from COVID

Building on the lessons of COVID, HIV vaccine advocates can mobilize for an HIV vaccine research and access agenda. This two-page document gives suggested messaging.

May 2021
AVAC
HIV Vaccine
By The Numbers

HIV Vaccines: An introductory factsheet

This is an updated introductory two-page document that describes HIV vaccines research and reviews key developments in the field.

September 2021
AVAC
HIV Vaccine
Fact Sheet
Training Material
Subscribe to RSS - HIV Vaccine